Clinical Trial Update: Docetaxel in Treating Patients With Relapsed Prostate Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated docetaxel in patients with relapsed prostate cancer. The study was terminated and results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: TERMINATED | Results posted: 2010-08-24